Alicaforsen therapy in inflammatory bowel disease
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.5.10.1387
Reference10 articles.
1. Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
2. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
3. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medical treatment of pouchitis: a guide for the clinician;Therapeutic Advances in Gastroenterology;2021-01
2. Evaluation of Acute Mountain Sickness by Unsedated Transnasal Esophagogastroduodenoscopy at High Altitude;Clinical Gastroenterology and Hepatology;2020-09
3. Alicaforsen, an antisense inhibitor of ICAM‐1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series;United European Gastroenterology Journal;2016-02
4. What's Next for Gastrointestinal Disorders: No Needles?;Journal of Controlled Release;2016-01
5. Novel Biologics for the Treatment of Ulcerative Colitis;Medical Therapy of Ulcerative Colitis;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3